Tubal, Manilyn C.

HRN: 16-69-48  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/16/2023
CO-AMOXICLAV 625MG (TAB)
03/16/2023
03/23/2023
ORAL
625mg
BID
2' RMLE; Lymphocytosis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: